4,868
Views
0
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Pharmacodynamics of D-mannose in the prevention of recurrent urinary infections

, , , &
Pages 459-464 | Received 03 Feb 2022, Accepted 30 Mar 2022, Published online: 13 Apr 2022

References

  • Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt)). 2012;21(3):347–354.
  • Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013;15(2):41–48.
  • Bonkat G, Bartoletti R, Bruyère F, et al. EAU guidelines on urological infections. Arnhem (The Netherlands): European Association of Urology; 2020.
  • Foxman B, Frerichs RR. Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health. 1985;75(11):1314–1317.
  • Eells SJ, Bharadwa K, McKinnell JA, et al. Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a Markov chain Monte Carlo model. Clin Infect Dis. 2014;58(2):147–160.
  • Berry RE, Klumpp DJ, Schaeffer AJ. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun. 2009;77(7):2762–2772.
  • Tamadonfar KO, Omattage NS, Spaulding CN, et al. Reaching the end of the line: urinary tract infections. Microbiol Spectr. 2019;7(3):BAI-0014-2019.
  • Mazzariol A, Bazaj A, Cornaglia G. Multi-drug-resistant gram-negative bacteria causing urinary tract infections: a review. J Chemother. 2017;29(sup1):2–9.
  • Kyriakides R, Jones P, Somani BK. Role of D-mannose in the prevention of recurrent urinary tract infections: evidence from a systematic review of the literature. Eur Urol Focus. 2021;7(5):1166–1169.
  • Lenger SM, Bradley MS, Thomas DA, et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020;223(2):265.e1–265.e13.
  • De Nunzio C, Bartoletti R, Tubaro A, et al. Role of D-mannose in the prevention of recurrent uncomplicated cystitis: state of the art and future perspectives. Antibiotics (Basel). 2021;10(4):373.
  • Alton G, Hasilik M, Niehues R, et al. Direct utilization of mannose for mammalian glycoprotein biosynthesis. Glycobiology. 1998;8(3):285–295.
  • Brument S, Sivignon A, Dumych TI, et al. Thiazolylaminomannosides as potent antiadhesives of type 1 piliated Escherichia coli isolated from Crohn's disease patients. J Med Chem. 2013;56(13):5395–5406.
  • Wood FC, Jr, Cahill GF, Jr. Mannose utilization in man. J Clin Invest. 1963;42:1300–1312.
  • Alton G, Kjaergaard S, Etchison JR, et al. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med. 1997;60(2):127–133.
  • Gulsun S, Oguzoglu N, Inan A, et al. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Saudi Med J. 2005;26(11):1755–1758.
  • Caretto M, Giannini A, Russo E, et al. Preventing urinary tract infections after menopause without antibiotics. Maturitas. 2017;99:43–46.
  • Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84.